1-deoxynojirimycin has been researched along with Cholera Infantum in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, K; Ito, Y; Muraoka, T; Terauchi, Y; Togashi, Y | 1 |
| Champion, H; Cox, TM; Gallagher, J; Imrie, J; Lachmann, RH; Ramaswami, U; Wraith, JE | 1 |
| Belmatoug, N; Burlina, A; Giraldo, P; Hendriksz, CJ; Kuter, DJ; Mengel, E; Pastores, GM | 1 |
| Drent, ML; Hoenderdos, EB; Jonker, JJ; Tollefsen, AT; van der Veen, EA; van Heusden, FH | 1 |
1 review(s) available for 1-deoxynojirimycin and Cholera Infantum
| Article | Year |
|---|---|
Gastrointestinal disturbances and their management in miglustat-treated patients.
Topics: 1-Deoxynojirimycin; Adult; Child; Clinical Trials as Topic; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Gastrointestinal Diseases; Gaucher Disease; Humans; Models, Biological | 2011 |
2 trial(s) available for 1-deoxynojirimycin and Cholera Infantum
| Article | Year |
|---|---|
Comparison of adverse gastrointestinal effects of acarbose and miglitol in healthy men: a crossover study.
Topics: 1-Deoxynojirimycin; Acarbose; Adult; Cross-Over Studies; Gastrointestinal Agents; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Male | 2010 |
Dose-dependent efficacy of miglitol, an alpha-glucosidase inhibitor, in type 2 diabetic patients on diet alone: results of a 24-week double-blind placebo-controlled study.
Topics: 1-Deoxynojirimycin; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Female; Food; Gastrointestinal Diseases; Glucosamine; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Male; Middle Aged; Placebos | 2002 |
1 other study(ies) available for 1-deoxynojirimycin and Cholera Infantum
| Article | Year |
|---|---|
Dietary modifications in patients receiving miglustat.
Topics: 1-Deoxynojirimycin; Adolescent; Adolescent Development; Adult; Age Factors; Child; Child Development; Diet, Carbohydrate-Restricted; England; Enzyme Inhibitors; Gastrointestinal Diseases; Glucosyltransferases; Humans; Lactose; Lysosomal Storage Diseases, Nervous System; Retrospective Studies; Time Factors; Treatment Outcome; Weight Loss; Young Adult | 2010 |